The results demonstrate that T0 treatment significantly ameliorates cognitive deficits seen in APP/E4/Abca1+/- mice, as examined by Novel Object Recognition and Contextual Fear Conditioning paradigms. This evidence concerns the gene ABCA1 and cognition.